RAPT Therapeutics shares surge 64% as GSK agrees $2.2B acquisition

Shares of RAPT Therapeutics surged sharply on Tuesday after the biopharmaceutical company said it had agreed to be acquired by British drugmaker GSK in a deal valued at about $2.2 billion, giving the ... ...